Home
Scholarly Works
Dipeptidyl Peptidase-4 Inhibitors May Reduce the...
Conference

Dipeptidyl Peptidase-4 Inhibitors May Reduce the Risk of Major Adverse Cardiovascular Events and All-cause Mortality In Patients With Type 2 Diabetes: Meta-analyses Oof Randomized Controlled Trials

Authors

Sun X; Hazzan AA; Bala M; Russe JW; Johnston BC; Carrasco-Labra A; Jankowski M; Neumann I; Ferreira-Gonzalez I; Fernandez-Balsells M

Volume

126

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

November 20, 2012

Conference proceedings

CIRCULATION

Issue

21

ISSN

0009-7322

Contact the Experts team